I can't speak for the company's business plan goals, but I'm told several hundred acres of this safflower crop could supply a majority of the insulin needs, especially for insulin in the developing world, where it's probably going to be used as an inhaled insulin or in a patch form, something that doesn't have to be refrigerated and injected. That market is still probably going to be fulfilled by the traditional type of insulin.
But SemBioSys is looking at the non-traditional uses, where there are tremendous needs in the developing world. They estimate a couple of hundred acres could supply a majority of that need.